N-Isopropylnorepinephrine en es it fr

N-Isopropylnorepinephrine Brand names, N-Isopropylnorepinephrine Analogs

N-Isopropylnorepinephrine Brand Names Mixture

  • No information avaliable

N-Isopropylnorepinephrine Chemical_Formula


N-Isopropylnorepinephrine RX_link


N-Isopropylnorepinephrine fda sheet

N-Isopropylnorepinephrine FDA

N-Isopropylnorepinephrine msds (material safety sheet)

N-Isopropylnorepinephrine Synthesis Reference

No information avaliable

N-Isopropylnorepinephrine Molecular Weight

211.258 g/mol

N-Isopropylnorepinephrine Melting Point

170.5 oC

N-Isopropylnorepinephrine H2O Solubility

No information avaliable

N-Isopropylnorepinephrine State


N-Isopropylnorepinephrine LogP


N-Isopropylnorepinephrine Dosage Forms


N-Isopropylnorepinephrine Indication

For the treatment of mild or transient episodes of heart block that do not require electric shock or pacemaker therapy also used in management of asthma and chronic bronchitis

N-Isopropylnorepinephrine Pharmacology

Isoproterenol is a relatively selective beta2-adrenergic bronchodilator. Isoproterenol is indicated for the relief of bronchospasm associated with chronic obstructive pulmonary disease. The pharmacologic effects of beta adrenergic agonist drugs, including Isoproterenol, are at least in part attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (ATP) to cyclic- 3',5'- adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

N-Isopropylnorepinephrine Absorption

No information avaliable

N-Isopropylnorepinephrine side effects and Toxicity

No information avaliable

N-Isopropylnorepinephrine Patient Information

No information avaliable

N-Isopropylnorepinephrine Organisms Affected

Humans and other mammals